The Cancer Genomics and Tumor Immunotherapy Symposium: A Clinical Perspective is a key educational event, jointly hosted by the Cancer Genomics Program (CGP) and the Tumor Immunotherapy Program (TIP) at the Princess Margaret Cancer Centre. The objective of this Symposium is to provide a clinical and translational perspective on cancer genomics and tumor immunotherapy by highlighting emerging therapies and technologies as they apply to precision cancer medicine at the point of care. Participants will learn about new research on mechanisms of resistance and response, emerging therapies and technologies aimed at increasing the personalized approach to treatment, and genomic applications in the clinic.

This one-day symposium will be held virtually this year.


Confirmed speakers include:

Deborah Schrag, MD, MPH, Dana-Farber Cancer Institute

Victor Ling, PhD, Terry Fox Research Institute

Sohrab Shah, PhD, Memorial Sloan Kettering Cancer Center

Dan Landau, MD, PhD, New York Genome Center

Emile Voest, MD, PhD, Netherlands Cancer Institute

Kathy McCoy, PhD, University of Calgary

John Hilton, MD, Ottawa Health Sciences Center

Grainne O’Kane, MD, Princess Margaret Cancer Centre


Target Audience for the 2020 Cancer Genomics and Tumor Immunotherapy Symposium:

  • Oncologists: Medical, Radiation, Surgical
  • Pathologists
  • Clinical Geneticists
  • Genetic Counselors
  • Laboratory Directors
  • Laboratory Technicians
  • Oncology Nurses
  • Bioinformaticians
  • Basic and Translational Scientists
  • Basic, Translational and Clinical Trainees
  • Pharmaceutical Representatives


Topics to be discussed in a presentation or panel include:

  • AACR PROJECT GENIE – Integrating Genomics & Phenomics Through Standardized Curation of Real-World Data
  • Terry Fox Marathon of Hope Comprehensive Cancer Centre Update
  • Single Cell RNA Sequencing and Clinical Applications
  • Molecular Residual Disease and ctDNA: Opportunities for Interception
  • The Role of Tumor Organoids in the Evaluation of Immunotherapy
  • Microbiome, Cancer and Inflammation
  • Debate: This house believes that there are therapeutic strategies to turn "cold" tumors into "hot" tumors